The integration of genome-based information for common diseases into health policy and healthcare as a major challenge for Public Health Genomics: The example of the methylenetetrahydrofolate reductase gene in non-cancer diseases

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 667, Issue 1-2, 2009, Pages 27-34

  Boccia, Stefania ^a   Brand, Angela ^b   Brand, Helmut ^b   Ricciardi, Gualtiero ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

MTHFR; Predictive medicine; Public Health Genomics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; ENZYME POLYMORPHISM; EPIDEMIOLOGY; GENOME; GENOMICS; HEALTH CARE; HEALTH CARE POLICY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MEDICAL INFORMATION SYSTEM; NONCANCER DISEASE; PHYSICAL DISEASE; PRIORITY JOURNAL; PUBLIC HEALTH;

CHRONIC DISEASE; DISEASE; GENETIC SCREENING; GENOMICS; HEALTH POLICY; HUMANS; META-ANALYSIS AS TOPIC; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PUBLIC HEALTH;

EID: 67649205007     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.10.003     Document Type: Article

References (80)

1. Hirschhorn N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6 (2005) 95-108
2. Collins F.S. Shattuck lecture-medical and societal consequences of the Human Genome Project. N. Engl. J. Med. 341 (1999) 28-37
3. Brand A. Public health and genetics-a dangerous combination? View-point section. Eur. J. Public Health 15 (2005) 113-116
4. Brand A., Brand H., and Schulte in den Bäumen T. The impact of genetics and genomics on public health. Eur. J. Hum. Genet. 16 (2008) 5-13
5. Brand A., Schröder P., Brand H., and Zimmern R. Getting ready for the future: integration of genomics into public health research, policy and practices in Europe and globally. Community Genet. 9 (2006) 67-71
6. Evaluation of Genomic Applications in Practice Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet. Med. 9 (2007) 819-825
7. Khoury M.J., Little J., Gwinn M., and Ioannidis J.P. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int. J. Epidemiol. 36 (2007) 439-445
8. Haddow J.E., and Palomaki G.E. ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury M., Little J., and Burke W. (Eds). Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease (2003), Oxford University Press 217-233
9. Brand H. Good governance for the public's health. Eur. J. Public Health 17 (2007) 541
10. Schröder-Bäck P. Principles for public health ethics-a transcultural approach. Eubios J. Asian Int. Bioeth. 17 (2007) 104-108
11. Brand A., and Brand H. Public health genomics-relevance of genomics for individual health information management, health policy development and effective health services. Ital. J. Public Health 4 (2006) 24-34
12. Varga E.A., Sturm A.C., Misita C.P., and Moll S. Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 111 (2005) e289-e293
13. Dallapiccola B., Torrente I., Morena A., Dagna-Bricarelli F., and Mingarelli R. Genetic testing in Italy, year 2004. Eur. J. Hum. Genet. 14 (2006) 911-916
14. Bellagio Statement. Genome-based Research and Population Health. Report of an expert workshop held at the Rockefeller Foundation Study and Conference Center, Bellagio, Italy, 14-20 April 2005.
15. Burke W., Khoury M., Stewart A., Zimmern R., and For the Bellagio Group. The path from genome-based research to population health: development of an international public health genomics network. Genet. Med. 8 (2006) 451-458
16. Ioannidis J.P., Bernstein J., Boffetta P., Danesh J., Dolan S., Hartge P., Hunter D., Inskip P., Jarvelin M.R., Little J., Maraganore D.M., Bishop J.A., O'Brien T.R., Petersen G., Riboli E., Seminara D., Taioli E., Uitterlinden A.G., Vineis P., Winn D.M., Salanti G., Higgins J.P., and Khoury M.J. A network of investigator networks in human genome epidemiology. Am. J. Epidemiol. 162 (2005) 302-304
17. Boccia S., Brand A., Brand H., Khoury M., and Zimmern R. Public health genomics in Europe. Ital. J. Public Health 3 (2006) 5-7
18. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202
19. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb. Haemost. 78 (1997) 523-526
20. Charles D.H., Ness A.R., Campbell D., Smith G.D., Whitley E., and Hall M.H. Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr. Perinat. Epidemiol. 19 (2005) 112-124
21. Botto L.D., and Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 151 (2000) 862-877
22. van der Put N.M., Gabreels F., Stevens E.M., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am. J. Hum. Genet. 62 (1998) 1044-1051
23. Xu X., Li J., Sheng W., and Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc. Dis. 26 (2008) 48-62
24. Ariyaratnam R., Casas J.P., Whittaker J., Smeeth L., Hingorani A.D., and Sharma P. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med. 4 (2007) e131
25. Banerjee V., Gupta S., and Ganesh. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J. Hum. Genet. 52 (2007) 205-219
26. Cronin S., Furie K.L., and Kelly P.J. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 36 (2005) 1581-1587
27. Casas J.P., Hingorani A.D., Bautista L.E., and Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch. Neurol. 61 (2004) 1652-1561
28. Kim R.J., and Becker R.C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am. Heart J. 146 (2003) 948-957
29. Kelly P.J., Rosand J., Kistler J.P., Shih V.E., Silveira S., Plomaritoglou A., and Furie K.L. Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59 (2002) 529-536
30. McColgan P., and Sharma P. cThe genetics of carotid dissection: meta-analysis of a MTHFR/C677T common molecular variant. Cerebrovasc. Dis. 25 (2008) 561-565
31. Den Heijer M., Lewington S., and Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J. Thromb. Haemost. 3 (2005) 292-299
32. Ray J.G., Shmorgun D., and Chan W.S. Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies. Pathophysiol. Haemost. Thromb. 32 (2002) 51-58
33. Lewis S.J., Ebrahim S., and Davey Smith G. Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. BMJ 331 (2005) 1053
34. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., Schouten E.G., and MTHFR Studies Collaboration Group. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 (2002) 2023-2031
35. Wu A.H., and Tsongalis G.J. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am. J. Cardiol. 87 (2001) 1361-1366
36. Jee S.H., Beaty T.H., Suh I., Yoon Y., and Appel L.J. The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations. Atherosclerosis 153 (2000) 161-168
37. van Beynum I.M., den Heijer M., Blom H.J., and Kapusta L. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 100 (2007) 743-753
38. Verkleij-Hagoort, Bliek J., Sayed-Tabatabaei F., Ursem N., Steegers E., and Steegers-Theunissen R. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am. J. Med. Genet. 143A (2007) 952-960
39. Gilbody S., Lewis S., and Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am. J. Epidemiol. 165 (2007) 1-13
40. Muntjewerff J.W., Kahn R.S., Blom H.J., and den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol. Psychiatry 11 (2006) 143-149
41. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr. Genet. 16 June 3 (2006) 105-115
42. Lewis S.J., Zammit S., Gunnell D., and Smith G.D. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 135 (2005) 2-4
43. Qian X., Lu Z., Tan M., Liu H., and Lu D. A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur. J. Hum. Genet. 15 (2007) 1239-1245
44. Lin J., and August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet. Gynecol. 105 (2005) 182-192
45. Kosmas I.P., Tatsioni A., and Ioannidis J.P. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J. Hypertens. 22 (2004) 1655-1562
46. Zusterzeel P.L., Visser W., Blom H.J., Peters W.H., Heil S.G., and Steegers E.A. Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hypertens. Pregnancy 19 (2000) 299-307
47. Zdoukopoulos N., and Zintzaras E. Genetic risk factors for placental abruption: a HuGE review and meta-analysis. Epidemiology 19 (2008) 309-323
48. Ren, and Wang. J. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis. Fertil. Steril. 86 (2006) 1716-1722
49. Nelen W.L., Blom H.J., Steegers E.A., den Heijer M., and Eskes T.K. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil. Steril. 74 (2000) 1196-1199
50. Amorim M.R., Lima M.A., Castilla E.E., and Orioli I.M. Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C > T: a meta-analysis. Am. J. Med. Genet. A 143A (2007) 1726-1732
51. López-León S., Janssens A.C., González-Zuloeta Ladd A.M., Del-Favero J., Claes S.J., Oostra B.A., and van Duijn C.M. Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry October 16 (2007)
52. Lewis S.J., Lawlor D.A., Davey Smith G., Araya R., Timpson N., Day I.N., and Ebrahim S. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol. Psychiatry 11 (2006) 352-360
53. Valero C., Alonso M.A., Zarrabeitia M.T., Viadero C., Hernández J.L., and Riancho J.A. MTHFR C677T polymorphism and osteoporotic fractures. Horm. Metab. Res. 39 (2007) 543-547
54. Janssen M.C., den Heijer M., Cruysberg J.R., Wollersheim H., and Bredie S.J. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb. Haemost. 93 (2005) 1021-1026
55. Cahill M.T., Stinnett S.S., and Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am. J. Ophthalmol. 136 (2003) 1136-1150
56. Lewis S., Lawlor D., Nordestgaard B., Tybjaerg-Hansen A., Ebrahim S., Zacho J., Ness A., Leary S., and Davey-Smith G. The MTHFR C677T genotype and the risk of obesity in 3 large population based Cohorts. Eur. J. Endocrinol. April 21 (2008)
57. Zintzaras E. Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. J. Hum. Genet. 52 (2007) 943-953
58. Zintzaras E., Uhlig K., Koukoulis G.N., Papathanasiou A.A., and Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J. Hum. Genet. 52 (2007) 881-890
59. Rubino E., Ferrero M., Rainero I., Binello E., Vaula G., and Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia August 21 (2007)
60. Brattström L., Wilcken D.E., Ohrvik J., and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98 (1998) 2520-2526
61. Kluijtmans L.A., and Whitehead A.S. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur. Heart J. 22 (2001) 294-299
62. Zintzaras E., Chatzoulis D.Z., Karabatsas C.H., and Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J. Hum. Genet. 50 (2005) 267-275
63. Tüttelmann F., Rajpert-De Meyts E., Nieschlag E., and Simoni M. Gene polymorphisms and male infertility-a meta-analysis and literature review. Reprod. Biomed. Online 15 (2007) 643-658
64. Thompson A.R., Drenos F., Hafez H., and Humphries S.E. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur. J. Vasc. Endovasc. Surg. 35 (2008) 19-30
65. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39 (2007) 17-23
66. Riancho J.A., Valero C., and Zarrabeitia M.T. MTHFR polymorphism and bone mineral density: meta-analysis of published studies. Calcif. Tissue Int. 79 (2006) 289-293
67. Keijzer M.B., Borm G.F., Blom H.J., Bos G.M., Rosendaal F.R., and den Heijer M. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study. Thromb. Haemost. 97 (2007) 32-37
68. Pan Z., Trikalinos T.A., Kavvoura F.K., Lau, and Ioannidis J.P. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Med. 2 (2005) e334
69. Chiuve S.E., Giovannucci E.L., Hankinson S.E., Hunter D.J., Stampfer M.J., Willett W.C., and Rimm E.B. Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine. Am. J. Clin. Nutr. 82 (2005) 155-162
70. McDonald S.D., Perkins S.L., Jodouin C.A., and Walker M.C. Folate levels in pregnant women who smoke: an important gene/environment interaction. Am. J. Obstet. Gynecol. 187 (2002) 620-625
71. Husemoen L.L., Thomsen T.F., Fenger M., and Jørgensen T. Effect of lifestyle factors on plasma total homocysteine concentrations in relation to MTHFR(C677T) genotype. Inter99 (7). Eur. J. Clin. Nutr. 58 (2004) 1142-1150
72. Hobbs C.A., James S.J., Jernigan S., Melnyk S., Lu Y., Malik S., and Cleves M.A. Congenital heart defects, maternal homocysteine, smoking, and the 677 C > T polymorphism in the methylenetetrahydrofolate reductase gene: evaluating gene-environment interactions. Am. J. Obstet. Gynecol. 194 (2006) 218-224
73. Zintzaras E., Giannouli S., Rodopoulou P., and Voulgarelis M. The role of MTHFR gene in multiple myeloma. J. Hum. Genet. (2008) Epub ahead of print
74. Lissowska J., Gaudet M.M., Brinton L.A., Chanock S.J., Peplonska B., Welch R., Zatonski W., Szeszenia-Dabrowska N., Park S., Sherman M., and Garcia-Closas M. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int. J. Cancer. 320 (2007) 2696-2703
75. Boccia S S., Hung R., Ricciardi G., Gianfagna F., Ebert M.P., Fang J.Y., Gao C.M., Götze T., Graziano F., Lacasaña-Navarro M., Lin D., López-Carrillo L., Qiao Y.L., Shen H., Stolzenberg-Solomon R., Takezaki T., Weng Y.R., Zhang F.F., van Duijn C.M., Boffetta P., and Taioli E. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a HuGE-GSEC review. Am. J. Epidemiol. 167 (2008) 505-516
76. Lee K.M., Lan Q., Kricker A., Purdue M.P., Grulich A.E., Vajdic C.M., Turner J., Whitby D., Kang D., Chanock S., Rothman N., and Armstrong B.K. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum. Genet. 122 (2007) 525-533
77. Pereira T.V., Rudnicki M., Pereira A.C., Pombo-de-Oliveira M.S., and Franco R.F. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1956-1963
78. Malinow M.R., Duell P.B., Hess D.L., et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N. Engl. J. Med. 338 (1998) 1009-1015
79. Davey Smith G., Ebrahim S., Lewis S., Hansell A.L., Palmer L.J., and Burton P.R. Genetic epidemiology and public health: hope, hype, and future prospects. Lancet 366 (2005) 1484-1498
80. Kamerow D. Waiting for the genetic revolution. BMJ 336 (2008) 22